Scholar Rock Holding Corp (SRRK)
10.79
-0.92
(-7.86%)
USD |
NASDAQ |
May 23, 16:00
10.78
-0.02
(-0.14%)
After-Hours: 20:00
Scholar Rock Cash from Investing (Quarterly): 33.38M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 33.38M |
December 31, 2023 | -25.13M |
September 30, 2023 | -8.473M |
June 30, 2023 | -15.24M |
March 31, 2023 | 89.98M |
December 31, 2022 | 0.077M |
September 30, 2022 | -145.72M |
June 30, 2022 | 44.52M |
March 31, 2022 | -70.58M |
December 31, 2021 | 29.46M |
September 30, 2021 | 3.283M |
June 30, 2021 | 79.02M |
March 31, 2021 | 22.56M |
December 31, 2020 | -122.64M |
September 30, 2020 | -35.87M |
Date | Value |
---|---|
June 30, 2020 | 38.93M |
March 31, 2020 | 56.09M |
December 31, 2019 | 21.21M |
September 30, 2019 | -72.17M |
June 30, 2019 | 21.10M |
March 31, 2019 | -32.38M |
December 31, 2018 | -60.94M |
September 30, 2018 | -0.598M |
June 30, 2018 | 24.89M |
March 31, 2018 | -23.59M |
December 31, 2017 | 5.898M |
September 30, 2017 | 8.975M |
June 30, 2017 | 1.424M |
March 31, 2017 | 1.368M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-145.72M
Minimum
Sep 2022
89.98M
Maximum
Mar 2023
-2.811M
Average
12.19M
Median
Cash from Investing (Quarterly) Benchmarks
Amgen Inc | -217.00M |
Eli Lilly and Co | -1.178B |
Ocular Therapeutix Inc | -0.255M |
Alpine Immune Sciences Inc | -2.562M |
X4 Pharmaceuticals Inc | -5.322M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -49.78M |
Cash from Financing (Quarterly) | 6.525M |
Free Cash Flow | -152.02M |
Free Cash Flow Per Share (Quarterly) | -0.5194 |
Free Cash Flow Yield | -16.12% |